Metalloprotease inhibitors
US6339092B1 · kind B1 · utility
2Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2000 |
| Grant date | Jan 15, 2002 |
| Priority date | — |
| Expiry date | Jun 30, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound selected from those of the formula (I): wherein:R1 represents hydrogen or halogen, or alkyl or alkoxy,R2 represents hydroxy, alkoxy or —NHOH,Ar1 represents phenylene or biphenylene,X represents oxygen or sulphur, NR, —C≡C— or a bond,R represents hydrogen or alkyl,n is an integer from 0 to 6 inclusive,Ar2 represents any one of the groups as defined in the description,its isomers and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful as metalloprotease inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.